Carmell (NASDAQ: CTCX) reported Q3 2023 earnings per share (EPS) of -$0.62, up 90.8% year over year. Total Carmell earnings for the quarter were -$11.51 million. In the same quarter last year, Carmell's earnings per share (EPS) was -$6.74.
As of Q4 2023, Carmell's earnings has grown year over year. Carmell's earnings in the past year totalled -$19.27 million.
What was CTCX's revenue last quarter?
Carmell (NASDAQ: CTCX) reported Q3 2023 revenue of $3.73 million up Infinity% year over year. In the same quarter last year, Carmell's revenue was $0.00.
What was CTCX's revenue growth in the past year?
As of Q4 2023, Carmell's revenue has grown 82.88% year over year. This is 27.7 percentage points lower than the US Biotechnology industry revenue growth rate of 110.58%. Carmell's revenue in the past year totalled $25.65 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.